Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Marker Therapeutics (NASDAQ:MRKR) through any online brokerage.
Other companies in Marker Therapeutics’s space includes: Serina Therapeutics Inc (AMEX:SER), Skye Bioscience Inc (NASDAQ:SKYE), Intensity Therapeutics Inc (NASDAQ:INTS), Evaxion AS (NASDAQ:EVAX) and Nanoviricides Inc (AMEX:NNVC).
Marker Therapeutics has a consensus price target of $12.38.
The stock price for Marker Therapeutics (NASDAQ: MRKR) is $1.5 last updated February 13, 2026 at 7:56 PM EST.
There are no upcoming dividends for Marker Therapeutics.
Marker Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Marker Therapeutics.
Marker Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.